SCHEMBL6595778

SCHEMBL6595778

COc1cc(CN2C(=O)N(C(CNC(C)CC(=O)OC(C)C)CC3CC3)C(=O)C2(C)C)ccc1NC(=O)Nc1ccccc1C

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 10/20 0.39
ITGB1 P05556 9/20 0.39
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPT P10636 1/20 0.34
CHEK1 O14757 2/20 0.33
LPAR1 Q92633 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
GAA P10253 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8358412 1.00 ITGA4 (0.39) ITGA4ITGB1MEN1KMT2AMAPT
SCHEMBL14222075 0.93 ITGA4 (0.39) ITGA4ITGB1MEN1KMT2AMAPT
SCHEMBL4672022 0.93 ITGA4 (0.39) ITGA4ITGB1MEN1KMT2AMAPT
SCHEMBL4671706 0.93 ITGA4 (0.46) ITGA4ITGB1MEN1KMT2AMAPT
SCHEMBL6515607 0.93 ITGA4 (0.46) ITGA4ITGB1MEN1KMT2AMAPT
SCHEMBL6515595 0.93 ITGA4 (0.46) ITGA4ITGB1MEN1KMT2AMAPT
SCHEMBL8360429 0.92 ITGA4 (0.41) ITGA4ITGB1MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL4674500 0.92 ITGA4 (0.45) ITGA4ITGB1MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL4674517 0.92 ITGA4 (0.45) ITGA4ITGB1MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL4674506 0.92 ITGA4 (0.45) ITGA4ITGB1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414444-A1 NOVEL IMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VLA-4 ANTAGONISTS Aventis Pharma Deutschland GmbH (DE) 2004-05-06 EP disclosed
WO-2003011288-A1 NOVEL IMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VLA-4 ANTAGONISTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-02-13 WO disclosed